Could retinoids be a potential treatment for rheumatic diseases?

Rheumatology International

Volumn 35, Issue 1, 2014, Pages 35-41

  Miyabe, Yoshishige ^a   Miyabe, Chie ^a   Nanki, Toshihiro ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

B cells; Retinoid; Rheumatic diseases; Rheumatoid arthritis; T cells

Indexed keywords

ELASTASE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; RETINOID;

B LYMPHOCYTE; CELL MIGRATION; CHEMOTAXIS; DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; T LYMPHOCYTE; ANIMAL; DISEASE MODEL; PILOT STUDY; RHEUMATIC DISEASES;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; PILOT PROJECTS; RETINOIDS; RHEUMATIC DISEASES;

EID: 84926633710     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3067-2     Document Type: Review

References (58)

1. Tanaka Y (2012) Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis. Curr Opin Rheumatol 24:319-326
2. Takeuchi T, Miyasaka N, Inoue K, Abe T, Koike T, RISING study (2009) Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study. Mod Rheumatol 19:478-487
3. Harigai M, Koike R, Miyasaka N, PPu A-TNFTPS Group (2007) Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med 357:1874-1876
4. Komano Y, Tanaka M, Nanki T, Koike R, Sakai R, Kameda H et al (2011) Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety. J Rheumatol 38:1258-1264
5. Tombetti E, Franchini S, Papa M, Sabbadini MG, Baldissera E (2013) Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center. J Rheumatol 40:2047-2051
6. Rouster-Stevens KA, Ferguson L, Morgan G, Huang CC, Pachman LM (2014) Pilot study of etanercept in patients with refractory juvenile dermatomyositis. Arthritis Care Res (Hoboken) 66:783-787
7. Bird HA, Hill J, Sitton NG, Dixon JS, Wright V (1988) A clinical and biochemical evaluation of etretinate in rheumatoid arthritis. Rheumatol Int 8:55-59
8. Gravallese EM, Handel ML, Coblyn J, Anderson RJ, Sperling RI, Karlson EW et al (1996) N-[4-hydroxyphenyl] retinamide in rheumatoid arthritis: a pilot study. Arthritis Rheum 39:1021-1026
9. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M et al (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-260
10. Sato A, Watanabe K, Kaneko K, Murakami Y, Ishido M, Miyasaka N et al (2010) The effect of synthetic retinoid, Am 80, on T helper cell development and antibody production in murine collagen-induced arthritis. Mod Rheumatol 20:244-251
11. Ohyanagi N, Ishido M, Suzuki F, Kaneko K, Kubota T, Miyasaka N et al (2009) Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo. Arthritis Rheum 60:3118-3127
12. Miyabe C, Miyabe Y, Miura NN, Takahashi K, Terashima Y, Toda E et al (2013) Am 80, a retinoic acid receptor agonist, ameliorates murine vasculitis through the suppression of neutrophil migration and activation. Arthritis Rheum 65:503-512
13. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954
14. Blomhoff R, Blomhoff HK (2006) Overview of retinoid metabolism and function. J Neurobiol 66:606-630
15. Mora JR, Iwata M, von Andrian UH (2008) Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8(9):685-698
16. van de Kerkhof PC (2006) Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther 19(5):252-263
17. Smith EV, Grindlay DJ, Williams HC (2011) What's new in acne? An analysis of systematic reviews published in 2009-2010. Clin Exp Dermatol 36:119-122 quiz 23
18. Kagechika H (2002) Novel synthetic retinoids and separation of the pleiotropic retinoidal activities. Curr Med Chem 9:591-608
19. Ohnishi K (2007) PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Int J Clin Oncol 12:313-317
20. Miwako I, Kagechika H (2007) Tamibarotene. Drugs Today 43:563-568
21. Iwata M, Eshima Y, Kagechika H (2003) Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol 15:1017-1025
22. Cantorna MT, Nashold FE, Hayes CE (1995) Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur J Immunol 25:1673-1679
23. Hoag KA, Nashold FE, Goverman J, Hayes CE (2002) Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells. J Nutr 132:3736-3739
24. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B et al (2008) Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181:2277-2284
25. Engedal N, Ertesvag A, Blomhoff HK (2004) Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2. Int Immunol 16:443-453
26. Ertesvag A, Engedal N, Naderi S, Blomhoff HK (2002) Retinoic acid stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid receptor-mediated IL-2 secretion. J Immunol 169:5555-5563
27. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY (2004) Retinoic acid imprints gut-homing specificity on T cells. Immunity 21:527-538
28. Barrington RA, Schneider TJ, Pitcher LA, Mempel TR, Ma M, Barteneva NS et al (2009) Uncoupling CD21 and CD19 of the B-cell coreceptor. Proc Natl Acad Sci USA 106:14490-14495
29. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y et al (1999) Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749-3752
30. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R et al (1995) Cp G motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549
31. Chen Q, Ross AC (2005) Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. Proc Natl Acad Sci USA 102:14142-14149
32. Chen Q, Ross AC (2007) Retinoic acid promotes mouse splenic B cell surface Ig G expression and maturation stimulated by CD40 and IL-4. Cell Immunol 249:37-45
33. Ertesvag A, Aasheim HC, Naderi S, Blomhoff HK (2007) Vitamin A potentiates Cp G-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK. Blood 109:3865-3872
34. Xu Z, Pone EJ, Al-Qahtani A, Park SR, Zan H, Casali P (2007) Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol 27:367-397
35. Watanabe K, Sugai M, Nambu Y, Osato M, Hayashi T, Kawaguchi M et al (2010) Requirement for Runx proteins in Ig A class switching acting downstream of TGF-beta 1 and retinoic acid signaling. J Immunol 184:2785-2792
36. Nagy L, Szanto A, Szatmari I, Széles L (2012) Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol Rev 92:739-789
37. Darmanin S, Chen J, Zhao S, Cui H, Shirkoohi R, Kubo N et al (2007) All-trans retinoic acid enhances murine dendritic cell migration to draining lymph nodes via the balance of matrix metalloproteinases and their inhibitors. J Immunol 179:4616-4625
38. Saurer L, McCullough KC, Summerfield A (2007) In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J Immunol 179:3504-3514
39. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR et al (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204:1775-1785
40. Kuwabara K, Shudo K, Hori Y (1996) Novel synthetic retinoic acid inhibits rat collagen arthritis and differentially affects serum immunoglobulin subclass levels. FEBS Lett 378:153-156
41. Zhu L, Bisgaier CL, Aviram M, Newton RS (1999) 9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells. Arterioscler Thromb Vasc Biol 19:2105-2111
42. Mehta K, McQueen T, Tucker S, Pandita R, Aggarwal BB (1994) Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J Leukoc Biol 55:336-342
43. Na SY, Kang BY, Chung SW, Han SJ, Ma X, Trinchieri G et al (1999) Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappa B. J Biol Chem 274:7674-7680
44. Wang X, Allen C, Ballow M (2007) Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages. J Clin Immunol 27:193-200
45. Montemurro P, Barbuti G, Conese M, Gabriele S, Petio M, Colucci M et al (1999) Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis. Br J Haematol 107:294-299
46. Yamada H, Mizuno S, Ross AC, Sugawara I (2007) Retinoic acid therapy attenuates the severity of tuberculosis while altering lymphocyte and macrophage numbers and cytokine expression in rats infected with Mycobacterium tuberculosis. J Nutr 137:2696-2700
47. Dzhagalov I, Chambon P, He YW (2007) Regulation of CD8+ T lymphocyte effector function and macrophage inflammatory cytokine production by retinoic acid receptor gamma. J Immunol 178:2113-2121
48. Gu B, Zhu Y, Zhu W, Miao J, Deng Y, Zou S (2009) Retinoid protects rats against neutrophil-induced oxidative stress in acute experimental mastitis. Int Immunopharmacol 9(2):223-229
49. Camisa C, Eisenstat B, Ragaz A, Weissmann G (1982) The effects of retinoids on neutrophil functions in vitro. J Am Acad Dermatol 6(4 pt 2 Suppl):620-629
50. Bohne M, Struy H, Gerber A, Gollnick H (1997) Effects of retinoids on the generation of neutrophil-derived reactive oxygen species studied by EPR spin trapping techniques. Inflamm Res 46:423-424
51. Coble BI, Dahlgren C, Molin L, Stendahl O (1987) Neutrophil function in psoriasis: effects of retinoids. Acta Derm Venereol 67:481-490
52. Yipp BG, Kubes P (2013) NETosis: how vital is it? Blood 122:2784-2794
53. Brinckerhoff CE, Coffey JW, Sullivan AC (1983) Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid. Science 221:756-758
54. Trentham DE, Brinckerhoff CE (1982) Augmentation of collagen arthritis by synthetic analogues of retinoic acid. J Immunol 129:2668-2672
55. Nozaki Y, Yamagata T, Yoo BS, Sugiyama M, Ikoma S, Kinoshita K et al (2005) The beneficial effects of treatment with all-transretinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice. Clin Exp Immunol 139:74-83
56. Kagechika H, Shudo K (2005) Synthetic retinoids: recent developments concerning structure and clinical utility. J Med Chem 48:5875-5883
57. Kinoshita K, Kishimoto K, Shimazu H, Nozaki Y, Sugiyama M, Ikoma S et al (2010) Successful treatment with retinoids in patients with lupus nephritis. Am J Kidney Dis 55:344-347
58. Ikeda T, Uede K, Hashizume H, Furukawa F (2004) The vitamin A derivative etretinate improves skin sclerosis in patients with systemic sclerosis. J Dermatol Sci 34:62-66